1Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
J Natl Compr Canc Netw. 2021 Jan 6;19(1):68-76. doi: 10.6004/jnccn.2020.7613.
The aim of this study was to assess the patterns and trends of colorectal, breast, and cervical cancer screening within a contemporary cohort of Canadian adults.
Canadian Community Health Survey datasets (2007-2016) were accessed and 3 cohorts were defined: (1) a colorectal cancer (CRC) screening cohort, defined as men and women aged 50 to 74 years with complete information about CRC screening tests and their timing; (2) a breast cancer screening cohort, defined as women aged 40 to 74 years with complete information about mammography and its timing; and (3) a cervical cancer screening cohort, defined as women aged 25 to 69 years with complete information about the Papanicolaou (Pap) test and its timing. Multivariable logistic regression analysis was then performed to evaluate factors associated with not having timely screening tests at the time of survey completion.
A total of 99,820 participants were considered eligible for the CRC screening cohort, 59,724 for the breast cancer screening cohort, and 46,767 for the cervical cancer screening cohort. Among eligible participants, 43% did not have timely recommended screening tests for CRC, 35% did not have timely mammography (this number decreased to 26% when limiting the eligible group to ages 50-74 years), and 25% did not have a timely Pap test. Lower income was associated with not having a timely recommended screening tests for all 3 cohorts (odds ratios [95% CI]: 1.86 [1.76-1.97], 1.89 [1.76-2.04], and 1.96 [1.79-2.14], respectively). Likewise, persons self-identifying as a visible minority were less likely to have timely recommended screening tests in all 3 cohorts (odds ratios for White race vs visible minority [95% CI]: 0.87 [0.83-0.92], 0.85 [0.80-0.91], and 0.66 [0.61-0.70], respectively).
More than one-third of eligible individuals are missing timely screening tests for CRC. Moreover, at least one-quarter of eligible women are missing their recommended breast and cervical cancer screening tests. More efforts from federal and provincial health authorities are needed to deal with socioeconomic disparities in access to cancer screening.
本研究旨在评估当代加拿大成年人中结直肠癌、乳腺癌和宫颈癌筛查的模式和趋势。
本研究使用加拿大社区健康调查数据集(2007-2016 年),定义了 3 个队列:(1)结直肠癌(CRC)筛查队列,定义为年龄在 50 至 74 岁之间、有完整 CRC 筛查检测及其时间信息的男性和女性;(2)乳腺癌筛查队列,定义为年龄在 40 至 74 岁之间、有完整乳房 X 线照片及其时间信息的女性;(3)宫颈癌筛查队列,定义为年龄在 25 至 69 岁之间、有完整巴氏试验(Pap 试验)及其时间信息的女性。然后进行多变量逻辑回归分析,以评估与在调查完成时未及时进行筛查检测相关的因素。
共有 99820 名参与者被认为符合 CRC 筛查队列的条件,59724 名参与者符合乳腺癌筛查队列的条件,46767 名参与者符合宫颈癌筛查队列的条件。在符合条件的参与者中,43%没有及时接受 CRC 的推荐筛查检测,35%没有及时接受乳房 X 线照片检查(当将符合条件的人群限定在 50-74 岁年龄组时,这一数字下降至 26%),25%没有及时进行 Pap 试验。较低的收入与所有 3 个队列中未及时进行推荐的筛查检测相关(比值比[95%置信区间]:1.86[1.76-1.97],1.89[1.76-2.04]和 1.96[1.79-2.14])。同样,自我认定为可见少数族裔的人在所有 3 个队列中都不太可能及时接受推荐的筛查检测(与白人种族相比的比值比[95%置信区间]:0.87[0.83-0.92],0.85[0.80-0.91]和 0.66[0.61-0.70])。
超过三分之一的合格个体错过了 CRC 的及时筛查检测。此外,至少四分之一的合格女性错过了其推荐的乳腺癌和宫颈癌筛查检测。联邦和省级卫生当局需要做出更多努力,以解决获得癌症筛查方面的社会经济差异。